Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Anemia peptide trials
13 selected ClinicalTrials.gov records carrying the official condition label Anemia. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
13 selected records.
1 profiles.
2012–2019 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 16 selected PubMed records and 1 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Anemia unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT00097747
PeptideScanner retained ClinicalTrials.gov record NCT00097747 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- December 21, 2012
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00228436
PeptideScanner retained ClinicalTrials.gov record NCT00228436 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- December 21, 2012
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00228449
PeptideScanner retained ClinicalTrials.gov record NCT00228449 at 2026-11-16T17:45:11.119Z. Its registry update date was 2012-12-21, and PeptideScanner's reviewed identity mapping was peginesatide.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- December 21, 2012
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Peginesatide · 2019-03-14
ClinicalTrials.gov record NCT00314795
Completed at the retained observation.
Open attributed record →Peginesatide · 2016-09-20
ClinicalTrials.gov record NCT01478971
Completed at the retained observation.
Open attributed record →Peginesatide · 2013-03-08
ClinicalTrials.gov record NCT00597584
Completed at the retained observation.
Open attributed record →Peginesatide · 2013-02-12
ClinicalTrials.gov record NCT00597753
Completed at the retained observation.
Open attributed record →Peginesatide · 2013-02-12
ClinicalTrials.gov record NCT00598273
Completed at the retained observation.
Open attributed record →Peginesatide · 2013-02-12
ClinicalTrials.gov record NCT00598442
Completed at the retained observation.
Open attributed record →Peginesatide · 2012-12-21
ClinicalTrials.gov record NCT00097747
Completed at the retained observation.
Open attributed record →Peginesatide · 2012-12-21
ClinicalTrials.gov record NCT00228436
Completed at the retained observation.
Open attributed record →Peginesatide · 2012-12-21
ClinicalTrials.gov record NCT00228449
Completed at the retained observation.
Open attributed record →Peginesatide · 2012-08-15
ClinicalTrials.gov record NCT00752791
Completed at the retained observation.
Open attributed record →Peginesatide · 2012-07-27
ClinicalTrials.gov record NCT00752609
Completed at the retained observation.
Open attributed record →Peginesatide · 2012-06-29
ClinicalTrials.gov record NCT00434330
Completed at the retained observation.
Open attributed record →Peginesatide · 2012-06-29
ClinicalTrials.gov record NCT00680043
Completed at the retained observation.
Open attributed record →